Medicine
Verapamil 120 mg extended-release tablet
Verapamil 120 mg extended-release tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Verapamil
- Brand
- Sold under the generic name
- Strength
- 120 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 90 tablets and 11 more
- Manufacturers
- Glenmark PharmaceuticalsIndiaCadila PharmaceuticalsIndiaProficient RxNivagen PharmaceuticalsPreferred PharmaceuticalsA-S Medication SolutionsNuCare Pharmaceuticals,Inc
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light and moisture and store in a dry place.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C08DA01 Verapamil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 August 2011
- Identifiers
- RxCUI 897659, 897640, 897649DailyMed set ID d23c757d-39f8-48c3-ba63-df2cbe58c516, 5501208c-aa2b-47aa-89f7-87f4d4a73fd0, ba1bf1ae-9347-4d17-998b-14bf7b5984ce +4NDC 68788-6328, 71209-104, 68462-292 +4Application ANDA090700, ANDA206173
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle | 71209-104-05 | Cadila PharmaceuticalsIndia | 27 December 2021 |
| 500 tablet, extended release in 1 bottle | 71209-104-10 | Cadila PharmaceuticalsIndia | 27 December 2021 |
| 100 tablet, film coated, extended release in 1 bottle | 68462-292-01 | Glenmark PharmaceuticalsIndia | 5 August 2011 |
| 500 tablet, film coated, extended release in 1 bottle | 68462-292-05 | Glenmark PharmaceuticalsIndia | 5 August 2011 |
| 90 tablet, film coated, extended release in 1 bottle | 68462-292-90 | Glenmark PharmaceuticalsIndia | 5 August 2011 |
| 100 tablet, film coated, extended release in 1 bottle | 75834-320-01 | Nivagen Pharmaceuticals | 2 January 2023 |
| 500 tablet, film coated, extended release in 1 bottle | 75834-320-05 | Nivagen Pharmaceuticals | 2 January 2023 |
| 90 tablet, film coated, extended release in 1 bottle | 50090-1400-1 | A-S Medication Solutions | 28 November 2014 |
| 100 tablet, film coated, extended release in 1 bottle | 68071-3446-0 | NuCare Pharmaceuticals,Inc | 22 June 2023 |
| 30 tablet, film coated, extended release in 1 bottle | 68788-6328-3 | Preferred Pharmaceuticals | 17 October 2016 |
| 60 tablet, film coated, extended release in 1 bottle | 68788-6328-6 | Preferred Pharmaceuticals | 28 September 2021 |
| 30 tablet, film coated, extended release in 1 bottle | 63187-849-30 | Proficient Rx | 5 August 2011 |
| 60 tablet, film coated, extended release in 1 bottle | 63187-849-60 | Proficient Rx | 5 August 2011 |
| 90 tablet, film coated, extended release in 1 bottle | 63187-849-90 | Proficient Rx | 5 August 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 12 August 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Verapamil
Clinical summary
Verapamil is a calcium channel blocker indicated for the treatment of supraventricular tachyarrhythmias, including rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] syndromes). MedsAcross supplies Verapamil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VerapamilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Verapamil Hydrochloride prescribing information (Exela Pharma Sciences) · U.S. National Library of Medicine, DailyMed
Need Verapamil 120 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.